TG Therapeutics, Inc. (TGTX) quarterly cash flow statement — complete operating, investing & financing history
TG Therapeutics, Inc. (TGTX) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | 21.37M | -17.89M | 19.66M | -23.15M | 7.44M | -28.71M | -25.64M | -12.21M | 5.54M | -8.21M | -13.21M | 83.7M | -42.01M | -59.9M | -23.87M | -34.49M | -49.12M | -68.69M | -86.91M | -67.2M |
| Operating CF Margin % | 8.89% | -8.73% | 10.21% | -14.32% | 5.27% | -23.76% | -23.7% | -14.55% | 7.54% | -12.93% | -30.04% | 50.48% | -261.32% | -767.68% | -29837.5% | -36696.81% | -8268.69% | -3407.19% | -3744.46% | -3310.39% |
| Operating CF Growth % | 187.37% | 37.68% | 176.67% | -89.7% | 34.32% | -249.88% | -94.1% | -114.58% | 113.18% | 86.3% | 44.66% | 342.66% | 14.48% | 12.79% | 72.53% | 48.67% | 18.37% | 15.57% | -67.05% | -18.87% |
| Net Income | 27.56M | 19.78M | 23.04M | 390.89M | 28.19M | 5.06M | 23.33M | 3.88M | 6.88M | -10.71M | -14.42M | 113.93M | -47.61M | -39.23M | -52.99M | -35.82M | -40.51M | -69.01M | -93.34M | -85.64M |
| Depreciation & Amortization | 85K | 80K | 7.52M | 62K | 59K | 56K | 62K | 64K | 72K | 82K | 91K | 126K | 85K | 121K | 126K | 129K | 131K | 129K | 133K | 129K |
| Stock-Based Compensation | 47.83M | 19.95M | 15.65M | 17.69M | 16.36M | 14.97M | 11.95M | 11.77M | 9.48M | 9.34M | 9.38M | 9.18M | 12.54M | 6.82M | 11.05M | 6.99M | -975K | 2.12M | 14.36M | 14M |
| Deferred Taxes | 4.57M | 3.86M | 18.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 8.02M | 8.2M | -635K | -367.08M | -430K | -262K | -242K | 3.9M | -231K | -854K | 24.06M | 573K | 1.15M | 710K | 937K | 1.53M | 654K | 989K | 693K | 749K |
| Working Capital Changes | -66.69M | -69.76M | -44.54M | -64.71M | -36.74M | -48.54M | -60.74M | -31.82M | -10.66M | -6.07M | -8.05M | -40.11M | -8.18M | -28.32M | 17.01M | -7.33M | -8.42M | -2.92M | -8.75M | 3.56M |
| Change in Receivables | -95.94M | -86.42M | -40.24M | -33.87M | -41.4M | -60.94M | -13.46M | -32.12M | -18.63M | -13.89M | -11.77M | -21.84M | -8.86M | -8.62M | 0 | 88K | 814K | 487K | -5K | -453K |
| Change in Inventory | -80.1M | -13.28M | 563K | 8.7M | 3.6M | -46.3M | -24.82M | -2.54M | -2.56M | -36.93M | -5.51M | -2.54M | -1.97M | -26.92M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 99.36M | 34.02M | 2.01M | -17.28M | 5.57M | 65.58M | 0 | 0 | 8.96M | 40.22M | 2.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -8.83M | -9.86M | -15.64M | 46.36M | -3.99M | -12.93M | 15.79M | -9.33M | 1.76M | -9.26M | -44.76M | -30.23M | 30.5M | -6.17M | 16.27M | -2.99M | 10.38M | -43.67M | 3.29M | -631K |
| Capital Expenditures | -344K | -51K | -67K | -80K | -42K | -25K | -21K | -24K | 0 | 0 | 0 | 0 | 0 | 0 | -3K | -4K | 0 | -7K | -80K | -79K |
| CapEx % of Revenue | 0.14% | 0.02% | 0.03% | 0.05% | 0.03% | 0.02% | 0.02% | 0.03% | - | - | - | - | - | - | 3.75% | 4.26% | - | 0.35% | 3.45% | 3.89% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 14.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 390.91M | 390.83M | 1.06M | -78.24M | -6.44M | -6.1M | -6.07M | 134.45M | 135K | 10K | -1K | 421K | 47.05M | 25.24M | 49K | 275K | 135K | -850K | 56M | -7.36M |
| Debt Issued (Net) | 492.66M | 490.06M | 0 | 0 | 0 | 0 | 0 | 137.26M | 0 | 0 | 0 | 0 | 0 | 25M | 0 | 0 | 0 | -975K | 53.57M | -7.39M |
| Equity Issued (Net) | -99.14M | -99.23M | 1.06M | -78.24M | -6.88M | -6.12M | -6.61M | -2.15M | 135K | 10K | -1K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 2.42M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -99.99M | -99.99M | 0 | -78.24M | -6.88M | -6.12M | -6.61M | -2.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -2.6M | 0 | 0 | 0 | 432K | 21K | 539K | -659K | 0 | 0 | 0 | 420K | 47.05M | 238K | 49K | 275K | 135K | 125K | 0 | 29K |
| Net Change in Cash | 403.45M | 363.06M | 5.08M | -55.03M | -3M | -47.75M | -15.93M | 112.92M | 7.43M | -17.46M | -57.97M | 53.9M | 35.54M | -40.83M | -7.55M | -37.21M | -38.6M | -113.21M | -27.62M | -75.19M |
| Free Cash Flow | 21.02M | -17.95M | 19.59M | -23.23M | 7.39M | -28.74M | -25.66M | -12.23M | 5.54M | -8.21M | -13.21M | 83.7M | -42.01M | -59.9M | -23.87M | -34.5M | -49.12M | -68.7M | -86.99M | -67.28M |
| FCF Margin % | 8.75% | -8.76% | 10.17% | -14.37% | 5.24% | -23.78% | -23.72% | -14.58% | 7.54% | -12.93% | -30.04% | 50.48% | -261.32% | -767.68% | -29841.25% | -36701.06% | -8268.69% | -3407.54% | -3747.91% | -3314.29% |
| FCF Growth % | 184.35% | 37.56% | 176.35% | -89.98% | 33.56% | -250.19% | -94.26% | -114.61% | 113.18% | 86.3% | 44.67% | 342.63% | 14.48% | 12.8% | 72.56% | 48.72% | 18.61% | 15.63% | -66.71% | -18.83% |
| FCF per Share | 0.13 | -0.11 | 0.12 | -0.14 | 0.05 | -0.18 | -0.16 | -0.08 | 0.03 | -0.06 | -0.09 | 0.54 | -0.30 | -0.43 | -0.17 | -0.25 | -0.36 | -0.51 | -0.66 | -0.51 |
| FCF Conversion (FCF/Net Income) | 2.75x | -0.90x | 0.85x | -0.06x | 0.26x | -5.67x | -1.10x | -3.15x | 0.80x | 0.77x | 0.92x | 0.73x | 0.88x | 1.53x | 0.45x | 0.96x | 1.21x | 1.00x | 0.93x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 6.1M | 6.1M | 0 | 6.42M | 7.11M | 0 | 0 | 0 | 0 | 2.18M | 1.75M | 1.54M | 1.29M | 1.04M | 1.58M | 768K | 604K |
| Taxes Paid | 0 | 0 | 0 | 1.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |